All In Biotech

Free tool

FAERS Monitor: Tenormin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018240 or its brand name (Tenormin, Atenolol). Reports on generic versions are filed under their own applications.

Reports

133,241

Serious

93,431

70% of reports

Hospitalization

48,042

Death reported

11,331

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective8,061
  • nausea7,924
  • fatigue7,694
  • diarrhoea7,124
  • dyspnoea6,387
  • dizziness6,333
  • headache5,989
  • pain5,767
  • asthenia5,012
  • fall4,728
  • arthralgia4,669
  • malaise4,305
  • vomiting4,232
  • hypertension4,111
  • off label use4,092

Reports by year received

View as table
YearReports
20044,208
20054,818
20064,685
20074,035
20084,456
20095,158
20106,629
20116,664
20127,429
20136,456
20148,239
20159,678
20169,111
20178,094
20188,469
20197,496
20206,223
20214,826
20224,230
20233,598
20243,327
20253,211
20262,195

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,920,918 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypertensionSignal4,1113.13.05,809
fallSignal4,7282.32.23,327
astheniaSignal5,0122.12.12,975
dizzinessSignal6,3332.02.03,284
dyspnoea6,3871.81.72,262
arthralgia4,6691.81.71,613
diarrhoea7,1241.81.72,338
nausea7,9241.61.61,766
fatigue7,6941.61.51,616
malaise4,3051.61.5862
headache5,9891.51.51,062
pain5,7671.51.4937
vomiting4,2321.41.4543
drug ineffective8,0611.00.911
off label use4,0920.70.7401

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.